Treatment Controversies in Prostate Cancer

Jeremie Calais, MD, PhD, a physician specializing in nuclear medicine and an associate professor at the University of California, Los Angeles (UCLA), recently spoke about the controversies and unresolved questions in the treatment of patients with prostate cancer.

During the 2024 US Prostate Cancer Conference (USPCC), medical oncologists, urologists, and various other professionals gathered to share valuable knowledge and enhance the care provided to patients with prostate cancer. Calais highlighted the importance of addressing controversies within the field and the benefits of a multidisciplinary approach to patient care.

Prostate cancer is becoming increasingly complex, with advancements in diagnostics, biomarkers, and treatment options. This complexity leads to uncertainties and the need for ongoing exploration and collaboration among specialists. Calais emphasized the importance of optimizing PET imaging and utilizing prostate-specific membrane antigen–targeted radiopharmaceutical therapy to improve treatment outcomes.

Overall, discussions at the conference focused on the evolving landscape of prostate cancer treatment and the importance of interdisciplinary collaboration to address emerging questions and challenges. Calais encouraged further exploration and collaboration among specialists to enhance patient care and outcomes in the field of nuclear medicine.

spot_img

More from this stream

Recomended

‘Willi Candra Appointed Chief Digital and Tech Officer at Conair’

Conair is focusing on its digital capabilities, adding Willi Candra to its leadership team as its chief digital and technology officer. The newly created role follows a...

Test-driving Lucid’s 2024 Air models and previewing the future ‘Mid-Size’ EVs

In addition to our recent drive of the Lucid Air Sapphire, we got the opportunity to test drive all of the American automaker’s 2024 models, including Pure, Touring, and Grand Touring, and have...

Swell ETH Restaking Fund Launched in Collaboration with DeSyn Protocol

DeSyn Protocol joins Swell to introduce a disruptive financial product that aims to change the manner people invest in decentralized finance. Powered by DeSyn Protocol’s cutting-edge technology, the...

‘Major Token Launchpad Revealed by Binance’

Binance is launching Binance Megadrop, a token launch platform that merges airdrops with interactive web3 quests to enhance user engagement and provide exclusive access to new web3 tokens.  The...

New Organizational Structure Unveiled by Generali

The Board of Directors of Generali, chaired by Andrea Sironi, has approved a new organizational structure to reflect its main activities proposed by Philippe Donnet, Group Chief Executive Officer. ...